Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
33%
Ph not_applicable
1
33%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

withdrawn133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_2

A Study of the Safety and Antiretroviral Activity of 3BNC117

NCT02588586
completednot_applicable

Towards HIV Functional Cure

NCT01876862
withdrawnphase_3

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

NCT00011128

Clinical Trials (3)

Showing 3 of 3 trials
NCT02588586Phase 2

A Study of the Safety and Antiretroviral Activity of 3BNC117

Completed
NCT01876862Not Applicable

Towards HIV Functional Cure

Completed
NCT00011128Phase 3

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3